R&D Consortium to Develop Optical Sorting of Stem Cells
News Dec 17, 2013
Danish project partners OptoRobotix (R&D performing SME) and Bioneer (technological service partner) and Dolomite will jointly develop a cutting edge stem cell handling technology. As the market leader in microfluidic design, Dolomite will exploit its latest offerings to transform from concept to biotech device. The collaboration recognizes Dolomite’s proven track of Productizing Science®, its unique business philosophy.
Named OPTISORT (E! 7790 OPTISORT), the platform is expected to provide ‘Sorting and analysis platform for fragile mammalian cells using novel combination of optical and droplet technology’. The areas of stem cell biology and mammalian cell based protein manufacturing are developing fast. The ability for gentle cell sorting technologies and methods is expected to enable customers exploit unprecedented applications of cell biology in technology. The Consortium combines novel optical and droplet technology to create a commercial attractive platform. The collaboration has awarded close to 1 million Euros with a view to benefit the biotechnology, pharmaceutical and molecular biology industry.
The collaboration is made possible by the Eurostars Programme – a European Joint Programme dedicated to the R&D performing SMEs, co-funded by the European Communities and 33 EUREKA member countries. Eurostars aims to stimulate SMEs with a promising potential for international collaborative research and innovation, enabling the route to international markets. Eurostars, the first European funding programme dedicated to innovation driven SMEs highlights their importance as essential sources of growth, employment, entrepreneurial skills, innovation and economic and social cohesion. On average, a Eurostars project has 3 to 4 Participants, 2-3 Countries, 29 Months duration, and €1.4M R&D budget. Of a total of 9807 applicants, 613 Projects were successfully funded with a total budget of €878M (€390M Estimated Public Funding).
Scientists at the University of Bristol have invented a new technology that could lead to the development of a new generation of smart surgical glues and dressings for chronic wounds. The new method involves re-engineering the membranes of stem cells to effectively “weld” the cells together.READ MORE
Zebrafish, in contrast to humans, have outstanding regenerative capacities: and can regrow brain cells from so-called progenitor cells. Scientists have now determined that these progenitor cells consist of eight different sub-populations. In a fish model of Alzheimer’s disease, only some of these populations increased proliferation to restore lost cells.READ MORE
A research team developed a microfluidic-based drug screening chip that identifies synergistic interactions between two antibiotics in eight hours. This chip can be a cell-based drug screening platform for exploring critical pharmacological patterns of antibiotic interactions, along with potential applications in screening other cell-type agents and guidance for clinical therapies.READ MORE